BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

231 related articles for article (PubMed ID: 19730245)

  • 1. Significance of mean platelet volume on prognosis of patients with and without aspirin resistance in settings of non-ST-segment elevated acute coronary syndromes.
    Aksu H; Ozer O; Unal H; Hobikoglu G; Norgaz T; Buturak A; Soylu O; Narin A
    Blood Coagul Fibrinolysis; 2009 Dec; 20(8):686-93. PubMed ID: 19730245
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognostic significance of mean platelet volume on admission in an unselected cohort of patients with non ST-segment elevation acute coronary syndrome.
    Taglieri N; Saia F; Rapezzi C; Marrozzini C; Bacchi Reggiani ML; Palmerini T; Ortolani P; Melandri G; Rosmini S; Cinti L; Alessi L; Vagnarelli F; Villani C; Branzi A; Marzocchi A
    Thromb Haemost; 2011 Jul; 106(1):132-40. PubMed ID: 21614413
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mean platelet volume is associated with culprit lesion severity and cardiac events in acute coronary syndromes without ST elevation.
    Dogan A; Aksoy F; Icli A; Arslan A; Varol E; Uysal BA; Ozaydin M; Erdogan D
    Blood Coagul Fibrinolysis; 2012 Jun; 23(4):324-30. PubMed ID: 22473051
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Could mean platelet volume be a predictive marker for acute myocardial infarction?
    Kiliçli-Camur N; Demirtunç R; Konuralp C; Eskiser A; Başaran Y
    Med Sci Monit; 2005 Aug; 11(8):CR387-92. PubMed ID: 16049381
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The clinical importance of laboratory-defined aspirin resistance in patients presenting with non-ST elevation acute coronary syndromes.
    Acikel S; Yildirir A; Aydinalp A; Bal U; Kaynar G; Ozin B; Muderrisoglu H
    Blood Coagul Fibrinolysis; 2009 Sep; 20(6):427-32. PubMed ID: 19542882
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Baseline platelet size is increased in patients with acute coronary syndromes developing early stent thrombosis and predicts future residual platelet reactivity. A case-control study.
    Huczek Z; Filipiak KJ; Kochman J; Michalak M; Roik M; Piatkowski R; Grabowski M; Postula M; Opolski G
    Thromb Res; 2010 May; 125(5):406-12. PubMed ID: 19786298
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cardiovascular death and nonfatal myocardial infarction in acute coronary syndrome patients receiving coronary stenting are predicted by residual platelet reactivity to ADP detected by a point-of-care assay: a 12-month follow-up.
    Marcucci R; Gori AM; Paniccia R; Giusti B; Valente S; Giglioli C; Buonamici P; Antoniucci D; Abbate R; Gensini GF
    Circulation; 2009 Jan; 119(2):237-42. PubMed ID: 19118249
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Usefulness of pregnancy-associated plasma protein A in patients with acute coronary syndrome.
    Iversen KK; Dalsgaard M; Teisner AS; Schoos M; Teisner B; Nielsen H; Clemmensen P; Grande P
    Am J Cardiol; 2009 Dec; 104(11):1465-71. PubMed ID: 19932776
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic value of mean platelet volume in patients with non-ST-elevation acute coronary syndrome.
    López-Cuenca AA; Tello-Montoliu A; Roldán V; Pérez-Berbel P; Valdés M; Marín F
    Angiology; 2012 May; 63(4):241-4. PubMed ID: 21733947
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical outcome prediction from mean platelet volume in patients undergoing percutaneous coronary intervention in Korean cohort: Implications of more simple and useful test than platelet function testing.
    Choi SW; Choi DH; Kim HW; Ku YH; Ha SI; Park G
    Platelets; 2014; 25(5):322-7. PubMed ID: 23909871
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Usefulness of aspirin resistance after percutaneous coronary intervention for acute myocardial infarction in predicting one-year major adverse coronary events.
    Marcucci R; Paniccia R; Antonucci E; Gori AM; Fedi S; Giglioli C; Valente S; Prisco D; Abbate R; Gensini GF
    Am J Cardiol; 2006 Nov; 98(9):1156-9. PubMed ID: 17056317
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mean platelet volume in predicting short- and long-term morbidity and mortality in patients with or without ST-segment elevation myocardial infarction.
    Tekbas E; Kara AF; Ariturk Z; Cil H; Islamoglu Y; Elbey MA; Soydinc S; Ulgen MS
    Scand J Clin Lab Invest; 2011 Nov; 71(7):613-9. PubMed ID: 21859357
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High post-treatment platelet reactivity is associated with a high incidence of myonecrosis after stenting for non-ST elevation acute coronary syndromes.
    Cuisset T; Frere C; Quilici J; Morange PE; Nait-Saidi L; Mielot C; Bali L; Lambert M; Alessi MC; Bonnet JL
    Thromb Haemost; 2007 Feb; 97(2):282-7. PubMed ID: 17264958
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A risk score to predict bleeding in patients with acute coronary syndromes.
    Mehran R; Pocock SJ; Nikolsky E; Clayton T; Dangas GD; Kirtane AJ; Parise H; Fahy M; Manoukian SV; Feit F; Ohman ME; Witzenbichler B; Guagliumi G; Lansky AJ; Stone GW
    J Am Coll Cardiol; 2010 Jun; 55(23):2556-66. PubMed ID: 20513595
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association of cyclooxygenase-1-dependent and -independent platelet function assays with adverse clinical outcomes in aspirin-treated patients presenting for cardiac catheterization.
    Frelinger AL; Li Y; Linden MD; Barnard MR; Fox ML; Christie DJ; Furman MI; Michelson AD
    Circulation; 2009 Dec; 120(25):2586-96. PubMed ID: 19996015
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impaired endogenous thrombolysis in acute coronary syndrome patients predicts cardiovascular death and nonfatal myocardial infarction.
    Saraf S; Christopoulos C; Salha IB; Stott DJ; Gorog DA
    J Am Coll Cardiol; 2010 May; 55(19):2107-15. PubMed ID: 20447533
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ischemia detected on continuous electrocardiography after acute coronary syndrome: observations from the MERLIN-TIMI 36 (Metabolic Efficiency With Ranolazine for Less Ischemia in Non-ST-Elevation Acute Coronary Syndrome-Thrombolysis In Myocardial Infarction 36) trial.
    Scirica BM; Morrow DA; Budaj A; Dalby AJ; Mohanavelu S; Qin J; Aroesty J; Hedgepeth CM; Stone PH; Braunwald E
    J Am Coll Cardiol; 2009 Apr; 53(16):1411-21. PubMed ID: 19371824
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-term prognostic value and therapeutic implications of continuous ST-segment monitoring in acute coronary syndrome.
    Yan AT; Yan RT; Tan M; Senaratne M; Fitchett DH; Langer A; Goodman SG;
    Am Heart J; 2007 Apr; 153(4):500-6. PubMed ID: 17383285
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diverging associations of an intended early invasive strategy compared with actual revascularization, and outcome in patients with non-ST-segment elevation acute coronary syndrome: the problem of treatment selection bias.
    Hirsch A; Windhausen F; Tijssen JG; Oude Ophuis AJ; van der Giessen WJ; van der Zee PM; Cornel JH; Verheugt FW; de Winter RJ;
    Eur Heart J; 2009 Mar; 30(6):645-54. PubMed ID: 18824461
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Platelet aspirin resistance in ED patients with suspected acute coronary syndrome.
    Glauser J; Emerman CL; Bhatt DL; Peacock WF
    Am J Emerg Med; 2010 May; 28(4):440-4. PubMed ID: 20466222
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.